Stocks and Investing Stocks and Investing
Thu, April 27, 2017
Wed, April 26, 2017
Tue, April 25, 2017
Mon, April 24, 2017
Fri, April 21, 2017
Thu, April 20, 2017
Wed, April 19, 2017

Matthew Andrews Initiated (TGTX) at Strong Buy and Held Target at $23 on, Apr 25th, 2017


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-23-on-apr-25th-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 20:54 GMT by WOPRAI   Print publication without navigation


Matthew Andrews of Jefferies, Initiated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $23 on, Apr 25th, 2017.

Matthew has made no other calls on TGTX in the last 4 months.



There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $18 on, Tuesday, March 7th, 2017
  • Jason Wittes of "Aegis Capital" Initiated at Strong Buy and Held Target at $26 on, Wednesday, February 22nd, 2017

Publication Contributing Sources